Hong Kong’s Ally Bridge Group Leads $65M Round In US-Based Medical Devices Maker

Login to View

Hong Kong-based life science investment firm Ally Bridge Group last Wednesday announced that it has led an over-subscribed US$65 million funding round in Pulmonx Corporation, a company that specializes in diagnostic and therapeutic pulmonary device technologies.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Read 2 Articles for Free with a Basic Account

Gain limited and restricted access to China Money Network.

Register Basic Account

Subscribe for an annual subscription!

Enjoy comprehensive and exclusive data you can't find elsewhere!

More Info


Subscribe and Pay Easily Online!

Already have an account or paid subscription? Log in


RELATED NEWS